Kurt Von Emster, Director at CymaBay Therapeutics, Inc. (CBAY), sold 182,978 shares at $12.23 ($2.2M) on 2018-01-31, disclosed to the SEC on 2018-02-01.
Open-market sale of $2.2M CBAY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.22 | 85,339 | $1.0M | 46.6% |
| 2 | $12.22 | 85,339 | $1.0M | 46.6% |
| 3 | $12.23 | 12,300 | $150K | 6.7% |
| Total | $12.22 avg | 182,978 | $2.2M | 100% |
| Filing → |
| VERA | BUY | 2021-05-18 | $8.9M | — | Filing → |
| PCVX | BUY | 2020-06-18 | $200K | — | Filing → |
| CRSP | SELL | 2019-01-18 | $3.7M | — | Filing → |